NCT06743919View on ClinicalTrials.gov

Adding Magnesium Sulfate or Dexmedetomidine to Bupivacaine in Oblique Subcostal Tap Block for Laparoscopic Cholecystectomy: a Randomized Double -Blind Controlled Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

Magnesium sulfate 50% - 1g/h

magnesium sulfate group 20 ml bupivacaine 0.25% plus 500 mg magnesium sulfate in 5ml normal saline on both sides.

DRUG

dexmedetomidine 0.5 µg/kg IV

dexmedetomidine group 20 ml bupivacaine 0.25% plus o .5 microg per kg dexmedetomidine in 5 ml normal saline on both sides.

DRUG

Bupivacaine

20 ml bupivacaine 0.25% plus 5 ml normal saline on both sides.

All Listed Sponsors
lead

Assiut University

OTHER